BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12893689)

  • 1. Mechanisms involved in adenosine triphosphate--induced platelet aggregation in whole blood.
    Stafford NP; Pink AE; White AE; Glenn JR; Heptinstall S
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1928-33. PubMed ID: 12893689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood.
    Glenn JR; White AE; Johnson A; Fox SC; Behan MW; Dolan G; Heptinstall S
    Platelets; 2005; 16(3-4):159-70. PubMed ID: 16011960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
    Harrison MJ; Brossmer R
    Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
    Bullough DA; Zhang C; Montag A; Mullane KM; Young MA
    J Clin Invest; 1994 Oct; 94(4):1524-32. PubMed ID: 7929829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
    Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
    Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: additional evidence for the role of ADP.
    Saniabadi AR; Lowe GD; Barbenel JC; Forbes CD
    Thromb Haemost; 1984 Feb; 51(1):115-8. PubMed ID: 6719381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.
    Evans PM
    Cytobios; 1978; 23(90):101-8. PubMed ID: 158489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct treatment of mouse or human blood with soluble 5'-nucleotidase inhibits platelet aggregation.
    Hart ML; Köhler D; Eckle T; Kloor D; Stahl GL; Eltzschig HK
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1477-83. PubMed ID: 18511695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
    Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women.
    Bar J; Lahav J; Hod M; Ben-Rafael Z; Weinberger I; Brosens J
    Thromb Haemost; 2000 Oct; 84(4):695-700. PubMed ID: 11057872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dipyridamole on spontaneous platelet aggregation in whole blood decreases with the time after venepuncture: evidence for the role of ADP.
    Saniabadi AR; Lowe GD; Barbenel JC; Forbes CD
    Thromb Haemost; 1987 Aug; 58(2):744-8. PubMed ID: 3672426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation?
    Beukers MW; Pirovano IM; van Weert A; Kerkhof CJ; IJzerman AP; Soudijn W
    Biochem Pharmacol; 1993 Dec; 46(11):1959-66. PubMed ID: 8267645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MK-447 on platelet shape change, aggregation, and ATP release by collagen, ADP, and stable analogue of thromboxane A2 in rabbit platelets.
    Li BY; Zhou H; Qiao GF; Wang L; Li WH
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):627-30. PubMed ID: 10678127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of ATP on platelet aggregation: cation interaction and shape change.
    Wang TY; Hussey CV; Garancis JC
    Ann Clin Lab Sci; 1977; 7(1):88-92. PubMed ID: 836006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
    Agarwal KC; Zielinski BA; Maitra RS
    Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
    Glenn JR; Heptinstall S
    Thromb Haemost; 1998 Aug; 80(2):321-5. PubMed ID: 9716160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of the evidence for the role of secreted ADP in biphasic platelet aggregation. Mechanism of inhibition by creatine phosphate plus creatine phosphokinase.
    Huang EM; Detwiler TC
    J Lab Clin Med; 1980 Jan; 95(1):59-68. PubMed ID: 7350241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.